Continue Reading

FDCS is a rare entity, especially those located in the intraperitoneal cavity. The diagnosis must be kept in mind when confronted with uncommon histological features in lymphoid tissue. A complete metabolic response after six courses of CHOP was achieved in a patient with FDCS.

Even though complete excision is currently known to be the best way to treat early stage FDCS, our case confirms other reports’ suggestion that ‘lymphoma-like’ chemotherapy could be a good option in patients with advanced unresectable disease.

Author Contributions

G. Liberale1, K. Keriakos1, M. A. Azerad2, N. De Saint Aubain3, and I. El Nakadi1

1Department of Digestive Surgery, Medical School, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium. 2Department of Medical Hematology, Medical School, Université Libre de Bruxelles, Jules Bordet Institute and CHU Brugmann, Brussels, Belgium. 3Department of Pathology, Medical School, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium.

Conceived and designed the experiments: GL. Analyzed the data: GL, KK. Wrote the first draft of the manuscript: GL. Contributed to the writing of the manuscript: KK, MAA, NSA. Agree with manuscript results and conclusions: GL, KK, MAA, NSA, IEN. Jointly developed the structure and arguments for the paper: GL. Made critical revisions and approved final version: GL, KK, MAA, NSA, IEN. All authors reviewed and approved of the final manuscript.

Disclosures and Ethics

As a requirement of publication the authors have provided signed confirmation of their compliance with ethical and legal obligations including but not limited to compliance with CMJauthorship and competing interests guidelines, that the article is neither under consideration for publication nor published elsewhere, of their compliance with legal and ethical guidelines concerning human and animal research participants (if applicable), and that permission has been obtained for reproduction of any copyrighted material. his article was subject to blind, independent, expert peer review. he reviewers reported no competing interests. 


  1. Monda L, Warnke R, Rosai J. A primary lymph node malignancy with features suggestive of dendrtitic reticulum cell differentiation, a report of 4 cases. Am J Pathol. 1986;122:562–72. 
  2. Chan JK, Fletcher CD, Nayler SJ, Cooper K. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer. 1997;79(2):294–313. 
  3. De Pas T, Spitaleri G, Pruneri G, et al. Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases. Crit Rev Oncol Hematol. 2008;65(1):1–7. 
  4. Perez-Ordoñez B, Rosai J. Follicular dendritic cell tumor: review of the entity. 
  5. Perez-Ordoñez B, Rosai J. Follicular dendritic cell tumor: review of the entity. Semin Diagn Pathol. 1998;15(2):144–54. 
  6. Han JH, Kim SH, Noh SH, Lee YC, Kim HG, Yang WI. Follicular dendritic cell sarcoma presenting as a submucosal tumor of the stomach. Arch Pathol Lab Med. 2000;124(11):1693–6. 
  7. Hollowood K, Stamp G, Zouvani I, Fletcher CD. Extranodal follicular dendritic cell sarcoma of the gastrointestinal tract. Morphologic, immunohistochemical and ultrastructural analysis of two cases. Am J Clin Pathol. 1995;103(1):90–7. 
  8. Sander B, Middel P, Gunawan B, et al. Follicular dendritic cell sarcoma of the spleen. Hum Pathol. 2007;38(4):668–72. 
  9. Geerts A, Lagae E, Dhaene K, et al. Metastatic follicular dendritic cell sarcoma of the stomach: a case report and review of the literature. Acta Gastroenterol Belg. 2004;67(2):223–7. 
  10. Chien-Feng L, Shih-Sung C, Ching-Nan L. A 70-year-old man with multiple intra-abdominal masses and liver and spleen metastases. Arch Pathol Lab Med. 2005;129:130–1. 
  11. Skarin A. Extranodal follicular dendritic cell tumor of the abdominal wall. J Clin Oncol. 1999;17(7):2290–2. 
  12. Yamakawa M, Andoh A, Masuda A, et al. Follicular dendritic cell sarcoma of the omentum. Virchows Arch. 2002;440(6):660–3. 
  13. Loo CK, Henderson C, Rogan K. Intraabdominal follicular dendritic cell sarcoma: report of a case with fine needle aspiration findings. Acta Cytol. 2001;45(6):999–1004. 
  14. Shinagare AB, Ramaiya NH, Jagannathan JP. Primary follicular dendritic cell sarcoma of liver treated with cyclophosphamide, doxorubicin, vincristine and prednisone regimen and surgery. J Clin Oncol. 2011;29:849–51. 
  15. Biddle DA, Ro JY, Yoon GS, et al. Extranodal follicular dendritic cell sarcoma of the head and neck region: three new cases, with a review of the literature. Mod Pathol. 2002;15(1):50–8. 
  16. Chera BS, Orlando C, Villaret DB, Mendenhall WM. Follicular dendritic cell sarcoma of the head and neck: case report and literature review. Laryngoscope. 2008;118(2):1107–12. 
  17. Fonseca R, Yamakawa M, Nakamura S, et al. Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review. Am J Hematol. 1998;59(2):161–7. 
  18. Chien JC-W, Lao WT, Chen C-L, Chan WP. Follicular dendritic cell sarcoma of the omentum: multidetector computed tomography findings. Gatsrointest Imaging. 2012;14(2):213–7. 
  19. Saygin C, Uzunaslan D, Ozguroglu M, Senocak M, Tuzuner N. Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case series. Crit Rev Oncol Hematol. 2013;88:253–71. 
  20. Hwang SO, Lee TH, Bae SH, et al. Transformation of Castleman’s disease into follicullar dendritic cell sarcoma, presenting as an asymptomatic intra-abdominal mass. Korean J Gastroenterol. 2013;62:131–4. 
  21. Soriano AO, Thompson MA, Admirand JH, et al. Follicular dendritic cell sarcoma a report of 14 cases and a review of literature. Am J Hematol. 2007;82(8):725–8. 
  22. Kohrt HE, Turnbull BB, Heydari K, et al. TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. Blood. 2009;114(5):1099–109. 

Source: Clinical Medicine Insights: Oncology